Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: A comparative analysis of a Mexican and a German population

Modern Pathology

Volumn 24, Issue 8, 2011, Pages 1046-1054

  Hofscheier, Annegret ^a   Ponciano, Ana ^b   Bonzheim, Irina ^a   Adam, Patrick ^a   Lome Maldonado, Carmen ^b   Vela, Teresa ^c   Cortes, Evelyn ^d   Ortiz Hidalgo, Carlos ^e   Fend, Falko ^a   Quintanilla Martinez, Leticia ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^d HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

^e American British Cowdry Medical Center   (Mexico)

Author keywords

EBV; elderly; large cell lymphoma; Mexico

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 2;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLONAL VARIATION; COMPARATIVE STUDY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE; GENE DELETION; GENOTYPE; GEOGRAPHICAL VARIATION (SPECIES); GERIATRICS; GERMANY; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; LMP1 GENE; MAJOR CLINICAL STUDY; MALE; MEXICO; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; VIRUS STRAIN;

AGE OF ONSET; AGED; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; GERMANY; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MEXICO; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

EID: 79961026198     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.62     Document Type: Article

References (24)

1. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000;343:481-492. (Pubitemid 30646489)
2. Gottschalk S, Rooney CM, Heslop HE. Post-transplant lymphoproliferative disorders. Annu Rev Med 2005;56:29-44. (Pubitemid 40299772)
3. Cohen JI, Kimura H, Nakamura S, et al. Epstein-Barr virus-associated lymphoproliferative disease in nonimmunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol 2009;20:1472-1482.
4. Cohen JI, Bollard CM, Khanna R, et al. Current understanding of the role of Epstein-Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas. Leuk Lymphoma 2008;49(Suppl 1):27-34.
5. Oyama T, Ichimura K, Suzuki R, et al. Senile EBV+ Bcell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 2003;27:16-26. (Pubitemid 36014895)
6. Oyama T, Yamamoto K, Asano N, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of patients. Clin Cancer Res 2007;13:5124-5132. (Pubitemid 47502080)
7. Park S, Lee J, Ko YH, et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 2007;110:972-978. (Pubitemid 47267436)
8. Nakamura S, Jaffe ES, Swerdlow SH. EBV positive diffuse large B-cell lymphoma of the elderly. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. International Agency for Research on Cancer: Lyon, 2008;243-244.
9. Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, et al. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol 1998;11:754-761. (Pubitemid 28381610)
10. Quintanilla-Martinez L, Kumar S, Fend F, et al. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 2000;96:443-451. (Pubitemid 30463361)
11. Quintanilla-Martinez L, Gamboa-Domnquez A, Gamez-Ledesma I, et al. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico. Mod Pathol 1995;8:675-679.
12. Gulley ML, Eagan PA, Quintanilla-Martinez L, et al. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity. Blood 1994;83: 1595-1602. (Pubitemid 24081574)
13. Gibson SE, Hsi ED. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol 2009;40:653-661.
14. Hoeller S, Tzankov A, Pileri SA, et al. Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in western populations. Hum Pathol 2010;41:352-357.
15. Quintanilla-Martinez L, Lome-Maldonado C, Schwarzmann F, et al. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A. Mod Pathol 1998;11:200-208. (Pubitemid 28144157)
16. Kingma DW, Weiss WB, Jaffe ES, et al. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996;88:242-251. (Pubitemid 26230693)
17. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 2003;17: 2257-2317. (Pubitemid 38072572)
18. Quintanilla-Martinez L, Lome-Maldonado C, Ott G, et al. Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases. Blood 1997;89:644-651. (Pubitemid 27051701)
19. Langer R, Geissinger E, Rudiger T, et al. Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone. Am J Surg Pathol 2010;34:1382-1387.
20. Quintanilla-Martinez L, de Jong D, de Mascarel A, et al. Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. J Hematop 2009;2:211-236.
21. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-768. (Pubitemid 39331148)
22. Chang CM, Yu KJ, Mbulaiteye SM, et al. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res 2009;143:209-221.
23. Dirnhofer S, Angeles-Angeles A, Ortiz-Hidalgo C, et al. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue. Hum Pathol 1999;30:781-787. (Pubitemid 29325784)
24. Asano N, Yamamoto K, Tamaru J, et al. Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 2009;113:2629-2636.